Drug recall D-1206-2018
Product
Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.
Reason for recall
Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.
Lots and codes
Lot: PW05264, Exp. 11/2019
Recall details
- Recalling firm
- Accord Healthcare, Inc., Durham, NC
- Quantity
- 46,632 bottles
- Distribution
- Nationwide in the USA and Puerto Rico.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 21, 2018
- Terminated
- May 7, 2020
Related products
- Hydrochlorothiazide – drug information
- NDC 16729-183 Hydrochlorothiazide · Hydrochlorothiazide 25 mg/1 · Accord Healthcare Inc.
- NDC 16729-182 Hydrochlorothiazide · Hydrochlorothiazide 12.5 mg/1 · Accord Healthcare Inc.
- NDC 16729-184 Hydrochlorothiazide · Hydrochlorothiazide 50 mg/1 · Accord Healthcare Inc.